The petition signals a growing fissure btwn NSGC and some of its members about how the organization should advocate for the rapidly growing profession amid increasing demand for genomics expertise in healthcare and deepening political divisions in the US. https://t.co/L4ErR9AKDO
@GenomeWeb@TurnaRay and mGC collaborate on a case series titled "Genetic Testing Challenges." Check out all prior articles in this series and send your case! https://t.co/OTK67wbX99 #genechat#precisionmedicine
A rare occasion: an international conference on Salomon Maimon in Germany. We will celebrate work on the new Maimon complete edition, in German and Hebrew, and the first English translation of his 1794 'Essay on a New Logic or Theory of Thinking'. Online attendance is possible.
Ordering carrier screening? Read how the wrong genetic test changed a family's life forever in new "Genetic Testing Challenges" article by @TurnaRay with @EllenMatloff: https://t.co/3Di5yHHEOS #genechat#precisionmedicine
Vertex says it wants to offer fertility support services to patients receiving its CRISPR-based gene therapy, which the HHS Office of Inspector General previously indicated would run afoul of anti-kickback laws - https://t.co/7bfZZoDF6V
NEW CASE--> explores the importance of taking a full family history when deciding when to order multigene versus single-site testing.
https://t.co/jJGVvT4ucq #genechat@OncoKB@MyGeneCounsel@EllenMatloff
In the era of doctors' notes being visible to patients (which I support!), we need to talk about:
* "chief complaint" [boilerplate language that already sounds too churlish]
* "SOB" {Shortness Of Breath!]
* "senile purpura"
* "occult"
* the doublespeak of positive/negative
Honored to chair this outstanding conference. 💥🔥🌈🎯
Nigel and Deanna Russell at Genome Web did a great job.
The speakers were so incredible that people were not looking at their iPhones.
Bring together academia, industry, patients to transform precision oncology
Healthcare providers are faced with challenges as genetic testing is increasingly used in patient care. Genetic Testing Challenges in Oncology is a case series to educate experts and foster discussion. To submit a case, email [email protected]#GeneChat#PrecisionMedicine
IRA @CMSGov drug price negotiations kicked off this week, and while the firms with selected drugs all begrudgingly -- but still voluntarily -- agreed to participate, they're determined to challenge the law's constitutionality in front of the highest courts https://t.co/VwUHvoiPMr
@US_FDA's decision to deny 510(k) clearance to a small PGx software firm's platform comes amid its efforts to oversee LDTs and certain software for guiding treatment. Translational Software's experience offers a glimpse into the FDA's evidence expectations https://t.co/uEqtYmbMJk
Check out the “Genetic Testing Challenges in Oncology" series that highlight real-world issues genetics experts & medical professionals are encountering as genetic tests are increasingly used in cancer care! It features mGC CEO @EllenMatloff#GeneChat#precisionmedicine
NEW CASE --> Genetic Testing Challenges in Oncology: Broad Panel Assessment Reveals Unexpected RET Finding #GeneChat@MyGeneCounsel@OncoAlert https://t.co/34mrqJLPE7